<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.ajmc.com/view/the-association-between-patient-out-of-pocket-medical-costs-and-medication-adherence</loc><lastmod>2026-09-10T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-10T16:00:00Z</news:publication_date>
        <news:title><![CDATA[The Association Between Patient Out-of-Pocket Medical Costs and Medication Adherence]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-the-gap-between-trials-and-real-world-care</loc><lastmod>2026-09-10T15:12:45.511Z</lastmod><news:news><news:publication_date>2026-09-10T15:12:45.511Z</news:publication_date>
        <news:title><![CDATA[Closing the Gap Between Trials and Real-World Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cancer-drug-shortages-persist-into-fourth-year-nccn-data-show</loc><lastmod>2026-09-10T15:05:00Z</lastmod><news:news><news:publication_date>2026-09-10T15:05:00Z</news:publication_date>
        <news:title><![CDATA[Cancer Drug Shortages Persist Into Fourth Year, NCCN Data Show]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/higher-weight-adjusted-waist-index-tied-to-ckd-mortality-study-finds</loc><lastmod>2026-09-10T13:30:00Z</lastmod><news:news><news:publication_date>2026-09-10T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Higher Weight-Adjusted Waist Index Tied to CKD Mortality, Study Finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/should-i-stay-or-should-i-go-provider-considerations-for-leaving-medicaid-managed-care-organizations</loc><lastmod>2026-09-10T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-10T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Should I Stay, or Should I Go? Provider Considerations for Leaving Medicaid Managed Care Organizations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hospital-program-restores-vision-cuts-costs-for-the-underinsured</loc><lastmod>2026-09-10T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-10T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Hospital Program Restores Vision, Cuts Costs for the Underinsured]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/inside-the-be-well-trials-design-population-and-patient-selection</loc><lastmod>2026-09-10T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-10T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Inside the Be-Well Trials: Design, Population, and Patient Selection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/clinical-trial-insights-in-retinal-vascular-diseases</loc><lastmod>2026-09-10T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-10T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Clinical Trial Insights in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/counseling-vitiligo-patients-on-time-to-repigmentation</loc><lastmod>2026-09-10T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-10T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Counseling Vitiligo Patients on Time to Repigmentation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/mechanisms-of-anti-vegf-therapies-in-retinal-vascular-diseases</loc><lastmod>2026-09-10T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-10T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Mechanisms of Anti-VEGF Therapies in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cross-trial-vitiligo-data-what-payers-can-and-can-t-compare</loc><lastmod>2026-09-10T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-10T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Cross-Trial Vitiligo Data: What Payers Can and Can't Compare]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/how-bepirovirsen-targets-the-hepatitis-b-viral-lifecycle</loc><lastmod>2026-09-10T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-10T12:00:00Z</news:publication_date>
        <news:title><![CDATA[How Bepirovirsen Targets the Hepatitis B Viral Lifecycle]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/texas-hospitals-lose-27-million-a-day-in-medicaid-funding-dispute</loc><lastmod>2026-09-09T21:36:44.993Z</lastmod><news:news><news:publication_date>2026-09-09T21:36:44.993Z</news:publication_date>
        <news:title><![CDATA[Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/addressing-finerenone-cost-access-in-heart-failure-trejeeve-martyn-md</loc><lastmod>2026-09-09T20:38:14.032Z</lastmod><news:news><news:publication_date>2026-09-09T20:38:14.032Z</news:publication_date>
        <news:title><![CDATA[Addressing Finerenone Cost, Access in Heart Failure: Trejeeve Martyn, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/significant-emphysema-linked-to-worse-ild-outcomes-yet-khor-md-phd</loc><lastmod>2026-09-09T19:45:00Z</lastmod><news:news><news:publication_date>2026-09-09T19:45:00Z</news:publication_date>
        <news:title><![CDATA[Significant Emphysema Linked to Worse ILD Outcomes: Yet Khor, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/inebilizumab-benefit-consistent-across-mg-subgroups-richard-nowak-md</loc><lastmod>2026-09-09T17:16:10.192Z</lastmod><news:news><news:publication_date>2026-09-09T17:16:10.192Z</news:publication_date>
        <news:title><![CDATA[Inebilizumab Benefit Consistent Across MG Subgroups: Richard Nowak, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/social-care-needs-real-networks-halima-ahmadi-montecalvo-phd-mph</loc><lastmod>2026-09-09T17:00:36.944Z</lastmod><news:news><news:publication_date>2026-09-09T17:00:36.944Z</news:publication_date>
        <news:title><![CDATA[Social Care Needs Real Networks: Halima Ahmadi-Montecalvo, PhD, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/mash-comorbidities-may-drive-worse-transplant-outcomes</loc><lastmod>2026-09-09T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-09T16:00:00Z</news:publication_date>
        <news:title><![CDATA[MASH Comorbidities May Drive Worse Transplant Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/plan-switching-among-medicare-advantage-enrollees-dually-eligible-for-medicaid</loc><lastmod>2026-09-09T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-09T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Plan Switching Among Medicare Advantage Enrollees Dually Eligible for Medicaid]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-one-big-beautiful-bill-act-and-cancer-care-what-oncology-leaders-need-to-know-and-do-now</loc><lastmod>2026-09-09T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-09T13:00:00Z</news:publication_date>
        <news:title><![CDATA[The One Big Beautiful Bill Act and Cancer Care: What Oncology Leaders Need to Know and Do Now]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tozorakimab-cuts-copd-exacerbations-up-to-34-in-phase-3-trials</loc><lastmod>2026-09-08T21:35:32.107Z</lastmod><news:news><news:publication_date>2026-09-08T21:35:32.107Z</news:publication_date>
        <news:title><![CDATA[Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tarlatamab-dlle-plus-durvalumab-improves-survival-in-first-line-es-sclc</loc><lastmod>2026-09-08T21:09:34.615Z</lastmod><news:news><news:publication_date>2026-09-08T21:09:34.615Z</news:publication_date>
        <news:title><![CDATA[Tarlatamab-dlle Plus Durvalumab Improves Survival in First-Line ES-SCLC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-first-disease-modifying-treatment-for-axd</loc><lastmod>2026-09-08T21:00:38.963Z</lastmod><news:news><news:publication_date>2026-09-08T21:00:38.963Z</news:publication_date>
        <news:title><![CDATA[FDA Approves First Disease-Modifying Treatment for AxD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/patient-reported-outcomes-may-help-predict-cll-sll-outcomes</loc><lastmod>2026-09-08T20:31:05.863Z</lastmod><news:news><news:publication_date>2026-09-08T20:31:05.863Z</news:publication_date>
        <news:title><![CDATA[Patient-Reported Outcomes May Help Predict CLL/SLL Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lung-transplant-trends-shift-to-older-adults-sicker-pediatric-cases</loc><lastmod>2026-09-08T20:21:21.627Z</lastmod><news:news><news:publication_date>2026-09-08T20:21:21.627Z</news:publication_date>
        <news:title><![CDATA[Lung Transplant Trends Shift to Older Adults, Sicker Pediatric Cases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/elective-pvi-linked-to-higher-amputation-risk-ken-cohen-md-facp</loc><lastmod>2026-09-08T19:41:32.694Z</lastmod><news:news><news:publication_date>2026-09-08T19:41:32.694Z</news:publication_date>
        <news:title><![CDATA[Elective PVI Linked to Higher Amputation Risk: Ken Cohen, MD, FACP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/trump-admin-awards-106m-to-expand-rural-health-care-in-ny-ri-mi</loc><lastmod>2026-09-08T18:57:17.254Z</lastmod><news:news><news:publication_date>2026-09-08T18:57:17.254Z</news:publication_date>
        <news:title><![CDATA[Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/one-treatment-two-targets-beam-302-in-aatd-john-hurst-md-phd</loc><lastmod>2026-09-08T17:46:34.933Z</lastmod><news:news><news:publication_date>2026-09-08T17:46:34.933Z</news:publication_date>
        <news:title><![CDATA[One Treatment, Two Targets: BEAM-302 in AATD: John Hurst, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/why-multidisciplinary-care-drives-copd-biologic-selection</loc><lastmod>2026-09-08T17:38:59.507Z</lastmod><news:news><news:publication_date>2026-09-08T17:38:59.507Z</news:publication_date>
        <news:title><![CDATA[Why Multidisciplinary Care Drives COPD Biologic Selection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cleveland-panel-weighs-new-hfpef-pathway-access-to-finerenone</loc><lastmod>2026-09-08T16:53:47.552Z</lastmod><news:news><news:publication_date>2026-09-08T16:53:47.552Z</news:publication_date>
        <news:title><![CDATA[Cleveland Panel Weighs New HFpEF Pathway, Access to Finerenone]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/moderate-to-severe-atopic-dermatitis-care-in-practice-disease-burden-and-integrated-care-pathways</loc><lastmod>2026-09-08T14:38:29.169Z</lastmod><news:news><news:publication_date>2026-09-08T14:38:29.169Z</news:publication_date>
        <news:title><![CDATA[Moderate to Severe Atopic Dermatitis Care in Practice: Disease Burden and Integrated Care Pathways]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tailoring-car-t-bispecific-use-in-myeloma-amandeep-godara-mbbs</loc><lastmod>2026-09-08T13:51:41.738Z</lastmod><news:news><news:publication_date>2026-09-08T13:51:41.738Z</news:publication_date>
        <news:title><![CDATA[Tailoring CAR T, Bispecific Use in Myeloma: Amandeep Godara, MBBS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fragmented-care-financial-strain-gender-gaps-define-life-with-copd</loc><lastmod>2026-09-08T10:30:00Z</lastmod><news:news><news:publication_date>2026-09-08T10:30:00Z</news:publication_date>
        <news:title><![CDATA[Fragmented Care, Financial Strain, Gender Gaps Define Life With COPD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/primary-care-capacity-gaps-threaten-respiratory-prevention</loc><lastmod>2026-09-07T14:35:46.798Z</lastmod><news:news><news:publication_date>2026-09-07T14:35:46.798Z</news:publication_date>
        <news:title><![CDATA[Primary Care Capacity Gaps Threaten Respiratory Prevention]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-true-cost-of-running-a-community-car-t-program</loc><lastmod>2026-09-07T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-07T12:05:00Z</news:publication_date>
        <news:title><![CDATA[The True Cost of Running a Community CAR T-Cell Program]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/all-oral-bedaquiline-regimen-for-refractory-mac-lung-disease</loc><lastmod>2026-09-07T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-07T12:05:00Z</news:publication_date>
        <news:title><![CDATA[All-Oral Bedaquiline Regimen for Refractory MAC Lung Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/expanding-access-to-anti-amyloid-therapy-the-case-for-primary-care-prescribing</loc><lastmod>2026-09-07T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-07T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Expanding Access to Anti-Amyloid Therapy: The Case for Primary Care Prescribing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/empowering-primary-care-early-alzheimer-s-detection-and-the-referral-pathway-challenge</loc><lastmod>2026-09-07T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-07T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bringing-car-t-cell-therapy-into-community-cancer-centers</loc><lastmod>2026-09-07T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-07T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Bringing CAR T-Cell Therapy Into Community Cancer Centers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/encore-trial-explores-earlier-amikacin-therapy-for-mac</loc><lastmod>2026-09-07T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-07T12:00:00Z</news:publication_date>
        <news:title><![CDATA[ENCORE Trial Explores Earlier Amikacin Therapy for MAC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/tozorakimab-curbs-multiple-copd-inflammatory-pathways-ers-data-show</loc><lastmod>2026-09-07T00:32:01.093Z</lastmod><news:news><news:publication_date>2026-09-07T00:32:01.093Z</news:publication_date>
        <news:title><![CDATA[Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/copernicos-trial-eosinophil-guided-ics-reduction-safe-in-copd-vestbo-says</loc><lastmod>2026-09-06T14:55:26.697Z</lastmod><news:news><news:publication_date>2026-09-06T14:55:26.697Z</news:publication_date>
        <news:title><![CDATA[COPERNICOS Trial: Eosinophil-Guided ICS Reduction Safe in COPD, Vestbo Says]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/copd-deaths-rival-heart-failure-exceed-prostate-and-breast-cancer</loc><lastmod>2026-09-06T06:00:00Z</lastmod><news:news><news:publication_date>2026-09-06T06:00:00Z</news:publication_date>
        <news:title><![CDATA[COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/elective-pvi-for-claudication-linked-to-higher-limb-loss-costs</loc><lastmod>2026-09-05T18:52:58.485Z</lastmod><news:news><news:publication_date>2026-09-05T18:52:58.485Z</news:publication_date>
        <news:title><![CDATA[Elective PVI for Claudication Linked to Higher Limb Loss, Costs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ai-model-flags-colorectal-cancer-on-routine-noncontrast-ct-scans</loc><lastmod>2026-09-05T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-05T16:00:00Z</news:publication_date>
        <news:title><![CDATA[AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-camizestrant-for-er-her2-mbc-with-esr1-mutations</loc><lastmod>2026-09-05T00:21:00Z</lastmod><news:news><news:publication_date>2026-09-05T00:21:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/vutrisiran-effects-consistent-with-without-tafamidis-in-attr-cm</loc><lastmod>2026-09-04T18:25:00Z</lastmod><news:news><news:publication_date>2026-09-04T18:25:00Z</news:publication_date>
        <news:title><![CDATA[Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-equity-access-weekly-roundup-september-4-2026</loc><lastmod>2026-09-04T18:00:00Z</lastmod><news:news><news:publication_date>2026-09-04T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Health Equity & Access Weekly Roundup: September 4, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/faq-kalshi-s-cancer-drug-betting-markets-raise-ethics-concerns</loc><lastmod>2026-09-04T17:15:00Z</lastmod><news:news><news:publication_date>2026-09-04T17:15:00Z</news:publication_date>
        <news:title><![CDATA[FAQ: Kalshi's Cancer Drug Betting Markets Raise Ethics Concerns]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/advance-planning-eases-bispecific-therapy-burden-for-patients</loc><lastmod>2026-09-04T17:05:49.272Z</lastmod><news:news><news:publication_date>2026-09-04T17:05:49.272Z</news:publication_date>
        <news:title><![CDATA[Advance Planning Eases Bispecific Therapy Burden for Patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/rusfertide-approval-aims-to-close-pv-hematocrit-control-gaps</loc><lastmod>2026-09-04T15:24:07.730Z</lastmod><news:news><news:publication_date>2026-09-04T15:24:07.730Z</news:publication_date>
        <news:title><![CDATA[Rusfertide Approval Aims to Close PV Hematocrit Control Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/gmg-rescue-therapy-access-varies-by-hospital-richard-nowak-md-ms</loc><lastmod>2026-09-04T14:30:00Z</lastmod><news:news><news:publication_date>2026-09-04T14:30:00Z</news:publication_date>
        <news:title><![CDATA[gMG Rescue Therapy Access Varies by Hospital: Richard Nowak, MD, MS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ajmc-in-the-press-september-4-2026</loc><lastmod>2026-09-04T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-04T13:00:00Z</news:publication_date>
        <news:title><![CDATA[AJMC® in the Press, September 4, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/designing-the-pharmacy-enterprise-of-2035</loc><lastmod>2026-09-03T23:00:00Z</lastmod><news:news><news:publication_date>2026-09-03T23:00:00Z</news:publication_date>
        <news:title><![CDATA[Designing the Pharmacy Enterprise of 2035]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hma-venetoclax-beats-chemo-in-aml-but-not-for-everyone-amir-fathi-md</loc><lastmod>2026-09-03T21:05:05.108Z</lastmod><news:news><news:publication_date>2026-09-03T21:05:05.108Z</news:publication_date>
        <news:title><![CDATA[HMA-Venetoclax Beats Chemo in AML but Not for Everyone: Amir Fathi, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ckm-guideline-aims-to-break-down-specialty-silos-keith-bellovich-do</loc><lastmod>2026-09-03T20:10:17.230Z</lastmod><news:news><news:publication_date>2026-09-03T20:10:17.230Z</news:publication_date>
        <news:title><![CDATA[CKM Guideline Aims to Break Down Specialty Silos: Keith Bellovich, DO]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/grocery-assistance-shows-potential-in-diabetes-care-and-beyond</loc><lastmod>2026-09-03T20:27:13.901Z</lastmod><news:news><news:publication_date>2026-09-03T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Grocery Assistance Shows Potential in Diabetes Care and Beyond]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/resource-demands-challenge-community-oncology-christos-vaklavas-md</loc><lastmod>2026-09-03T16:15:36.396Z</lastmod><news:news><news:publication_date>2026-09-03T16:15:36.396Z</news:publication_date>
        <news:title><![CDATA[Resource Demands Challenge Community Oncology: Christos Vaklavas, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/abdominal-symptoms-track-closely-with-fear-of-recurrence-in-crc</loc><lastmod>2026-09-03T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-03T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Abdominal Symptoms Track Closely With Fear of Recurrence in CRC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/car-t-access-challenged-by-geography-cost-and-treatment-delays</loc><lastmod>2026-09-03T15:15:23.703Z</lastmod><news:news><news:publication_date>2026-09-03T15:15:23.703Z</news:publication_date>
        <news:title><![CDATA[CAR T Access Challenged by Geography, Cost, and Treatment Delays]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/access-logistics-shape-multiple-myeloma-immunotherapy-decisions</loc><lastmod>2026-09-03T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-03T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Access, Logistics Shape Multiple Myeloma Immunotherapy Decisions]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/from-the-exam-room-to-the-formulary-access-challenges-in-adjunctive-mdd-therapy</loc><lastmod>2026-09-03T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:05:00Z</news:publication_date>
        <news:title><![CDATA[From the Exam Room to the Formulary: Access Challenges in Adjunctive MDD Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/treat-and-extend-strategies-in-retinal-vascular-diseases</loc><lastmod>2026-09-03T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Treat-and-Extend Strategies in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/treat-and-extend-in-retinal-vascular-diseases</loc><lastmod>2026-09-03T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Treat-and-Extend in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/rethinking-standard-of-care-and-the-promise-of-functional-cure</loc><lastmod>2026-09-03T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Rethinking Standard of Care and the Promise of Functional Cure]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/unmet-needs-and-mechanisms-understanding-adjunctive-antipsychotics-in-mdd</loc><lastmod>2026-09-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Unmet Needs and Mechanisms: Understanding Adjunctive Antipsychotics in MDD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/treatment-goals-and-disease-management-in-retinal-vascular-diseases</loc><lastmod>2026-09-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Treatment Goals and Disease Management in Retinal Vascular Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-next-frontier-in-hepatitis-b-functional-and-virologic-cure</loc><lastmod>2026-09-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Next Frontier in Hepatitis B Functional and Virologic Cure]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/looking-ahead-optimism-emerging-therapies-and-the-future-of-rrfl-care</loc><lastmod>2026-09-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Looking Ahead: Optimism, Emerging Therapies, and the Future of RRFL Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/less-intensive-leukemia-regimen-outperforms-standard-chemo</loc><lastmod>2026-09-02T21:00:00Z</lastmod><news:news><news:publication_date>2026-09-02T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Less-Intensive Leukemia Regimen Outperforms Standard Chemo]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/how-long-acting-injectables-are-changing-hiv-care</loc><lastmod>2026-09-02T19:24:56.212Z</lastmod><news:news><news:publication_date>2026-09-02T19:24:56.212Z</news:publication_date>
        <news:title><![CDATA[How Long-Acting Injectables Are Changing HIV Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/historical-redlining-linked-to-lower-breast-cancer-screening</loc><lastmod>2026-09-02T19:14:06.903Z</lastmod><news:news><news:publication_date>2026-09-02T19:14:06.903Z</news:publication_date>
        <news:title><![CDATA[Historical Redlining Linked to Lower Breast Cancer Screening]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/why-cardiac-diagnoses-are-more-reliable-than-mortality-data-eman-toraih-md-phd</loc><lastmod>2026-09-02T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-02T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Why Cardiac Diagnoses Are More Reliable Than Mortality Data: Eman Toraih, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cannabis-edibles-impair-driving-below-legal-thc-thresholds-trial-finds</loc><lastmod>2026-09-02T16:03:04.833Z</lastmod><news:news><news:publication_date>2026-09-02T16:03:04.833Z</news:publication_date>
        <news:title><![CDATA[Cannabis Edibles Impair Driving Below Legal THC Thresholds, Trial Finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/unlocking-access-operationalizing-car-t-cell-therapy-in-the-community</loc><lastmod>2026-09-02T14:43:41.172Z</lastmod><news:news><news:publication_date>2026-09-02T14:43:41.172Z</news:publication_date>
        <news:title><![CDATA[Unlocking Access: Operationalizing CAR T-Cell Therapy in the Community]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/treating-adolescents-with-vitiligo-adherence-and-age-matter</loc><lastmod>2026-09-02T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-02T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Treating Adolescents With Vitiligo: Adherence and Age Matter]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/how-trial-enrollment-criteria-shape-vitiligo-coverage-policy</loc><lastmod>2026-09-02T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-02T12:00:00Z</news:publication_date>
        <news:title><![CDATA[How Trial Enrollment Criteria Shape Vitiligo Coverage Policy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/why-black-women-face-higher-hiv-risk-lower-prep-access</loc><lastmod>2026-09-01T21:40:37.009Z</lastmod><news:news><news:publication_date>2026-09-01T21:40:37.009Z</news:publication_date>
        <news:title><![CDATA[Why Black Women Face Higher HIV Risk, Lower PrEP Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fda-approves-ropeginterferon-alfa-2b-in-essential-thrombocythemia</loc><lastmod>2026-09-01T21:22:27.140Z</lastmod><news:news><news:publication_date>2026-09-01T21:22:27.140Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Ropeginterferon Alfa-2b in Essential Thrombocythemia]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/inside-myeloma-s-evolution-from-death-sentence-to-cure</loc><lastmod>2026-09-01T20:00:00Z</lastmod><news:news><news:publication_date>2026-09-01T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Inside Myeloma’s Evolution From Death Sentence to Cure]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/distance-telehealth-access-complicate-cancer-care-in-the-mountain-west</loc><lastmod>2026-09-01T20:00:00Z</lastmod><news:news><news:publication_date>2026-09-01T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Distance, Telehealth Access Complicate Cancer Care in the Mountain West]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cleaning-products-irritants-tied-to-severe-hand-eczema-in-adults</loc><lastmod>2026-09-01T19:32:23.886Z</lastmod><news:news><news:publication_date>2026-09-01T19:32:23.886Z</news:publication_date>
        <news:title><![CDATA[Cleaning Products, Irritants Tied to Severe Hand Eczema in Adults]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cardiac-risks-of-covid-19-vaccine-vs-infection-eman-toraih-md-phd</loc><lastmod>2026-09-01T18:00:24.056Z</lastmod><news:news><news:publication_date>2026-09-01T18:00:24.056Z</news:publication_date>
        <news:title><![CDATA[Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/patient-disease-factors-shape-multiple-myeloma-treatment-decisions</loc><lastmod>2026-09-01T18:00:00Z</lastmod><news:news><news:publication_date>2026-09-01T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Patient, Disease Factors Shape Multiple Myeloma Treatment Decisions]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/faq-why-costco-experts-weigh-in-on-scan-health-s-new-ma-plan</loc><lastmod>2026-09-01T17:55:00Z</lastmod><news:news><news:publication_date>2026-09-01T17:55:00Z</news:publication_date>
        <news:title><![CDATA[FAQ: Why Costco? Experts Weigh In on SCAN Health’s New MA Plan]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/addressing-biomarker-testing-gaps-in-nsclc-shiven-b-patel-md-mba</loc><lastmod>2026-09-01T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-01T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Addressing Biomarker Testing Gaps in NSCLC: Shiven B. Patel, MD, MBA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/nfl-dementia-deaths-often-miss-neurodegenerative-diagnosis</loc><lastmod>2026-09-01T15:00:00Z</lastmod><news:news><news:publication_date>2026-09-01T15:00:00Z</news:publication_date>
        <news:title><![CDATA[NFL Dementia Deaths Often Miss Neurodegenerative Diagnosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/better-cardiovascular-health-tied-to-lower-overactive-bladder-risk</loc><lastmod>2026-09-01T14:30:00Z</lastmod><news:news><news:publication_date>2026-09-01T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Better Cardiovascular Health Tied to Lower Overactive Bladder Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/evolocumab-cuts-death-risk-for-a-first-heart-attack-or-stroke</loc><lastmod>2026-09-01T13:45:34.773Z</lastmod><news:news><news:publication_date>2026-09-01T13:45:34.773Z</news:publication_date>
        <news:title><![CDATA[Evolocumab Cuts Death Risk for a First Heart Attack or Stroke]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lung-cancer-risk-models-are-multiplying-faster-than-they-can-be-validated</loc><lastmod>2026-09-01T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-01T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Lung Cancer Risk Models Are Multiplying Faster Than They Can Be Validated]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/vesalt-alopecia-areata-severity-tool-eyebrows-eyelashes-beard</loc><lastmod>2026-09-01T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-01T13:00:00Z</news:publication_date>
        <news:title><![CDATA[New Visual Scoring Tool Extends Alopecia Areata Assessment Beyond the Scalp]]></news:title>
        <news:keywords><![CDATA[alopecia areata,VESALT,Severity of Alopecia Tool (SALT),androgenetic alopecia,eyebrow and eyelash loss,beard alopecia areata,interrater reliability,clinical outcome assessment,hair loss severity scoring,teledermatology,News]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/physical-function-views-differ-between-older-aml-patients-clinicians</loc><lastmod>2026-08-31T21:58:58.716Z</lastmod><news:news><news:publication_date>2026-08-31T21:58:58.716Z</news:publication_date>
        <news:title><![CDATA[Physical Function Views Differ Between Older AML Patients, Clinicians]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/midsized-biotechs-strike-mfn-drug-pricing-deals</loc><lastmod>2026-08-31T20:29:16.094Z</lastmod><news:news><news:publication_date>2026-08-31T20:29:16.094Z</news:publication_date>
        <news:title><![CDATA[Midsized Biotechs Strike MFN Drug Pricing Deals]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/medicare-part-d-s-glp-1-dilemma-adam-colborn-jd</loc><lastmod>2026-08-31T19:08:10.749Z</lastmod><news:news><news:publication_date>2026-08-31T19:08:10.749Z</news:publication_date>
        <news:title><![CDATA[Medicare Part D’s GLP-1 Dilemma: Adam Colborn, JD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/selinexor-shows-modest-spleen-response-in-jak-inhibitor-refractory-mf</loc><lastmod>2026-08-31T17:36:28.816Z</lastmod><news:news><news:publication_date>2026-08-31T17:36:28.816Z</news:publication_date>
        <news:title><![CDATA[Selinexor Shows Modest Spleen Response in JAK Inhibitor–Refractory MF]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/multiagonists-outpace-older-glp-1-drugs-for-weight-loss</loc><lastmod>2026-08-31T21:00:00Z</lastmod><news:news><news:publication_date>2026-08-31T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Multiagonists Outpace Older GLP-1 Drugs for Weight Loss]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/cpfe-why-spirometry-alone-misses-emphysema-in-fibrotic-ild</loc><lastmod>2026-08-31T15:04:32.336Z</lastmod><news:news><news:publication_date>2026-08-31T15:04:32.336Z</news:publication_date>
        <news:title><![CDATA[CPFE: Why Spirometry Alone Misses Emphysema in Fibrotic ILD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ffrct-helps-cut-unnecessary-heart-angiograms-by-44-</loc><lastmod>2026-08-31T14:07:00Z</lastmod><news:news><news:publication_date>2026-08-31T14:07:00Z</news:publication_date>
        <news:title><![CDATA[FFRCT Helps Cut Unnecessary Heart Angiograms by 44%]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-registry-data-on-mac-pulmonary-disease-outcomes</loc><lastmod>2026-08-31T12:05:00.000Z</lastmod><news:news><news:publication_date>2026-08-31T12:05:00Z</news:publication_date>
        <news:title><![CDATA[New Registry Data on MAC Pulmonary Disease Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/what-fact-accreditation-requires-and-whether-it-s-necessary</loc><lastmod>2026-08-31T12:05:00Z</lastmod><news:news><news:publication_date>2026-08-31T12:05:00Z</news:publication_date>
        <news:title><![CDATA[What FACT Accreditation Requires and Whether It's Necessary]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>